与 «HYPERACUTE»相关的英语书籍
在以下的参考文献中发现
hyperacute的用法。与
hyperacute相关的书籍以及同一来源的简短摘要提供其在 英语文献中的使用情境。
1
Clinical Ocular Pharmacology
Figure 25-7 Hyperacute bacterial conjunctivitis with copious purulent discharge.
N. meningitidis. Other pathogens that can cause hyperacute conjunctivitis include
S. aureus, Streptococcus species, H. influenzae, Moraxella (Branhamella) ...
Jimmy D. Bartlett, Siret D. Jaanus, 2008
The role of complement in hyperacute rejection is inferred both from the
accumulation of various complement components in the grafts and from the fact
that complement depletion leads to prolonged survival of xenografts (148) .
Complement ...
3
Clinical Infectious Disease
Definitive evaluation and specific treatment is, however, required in hyperacute
conjunctivitis, a rapidly progressive, purulent, destructive infection, and neonatal
conjunctivitis to avoid local and systemic complications more common to these ...
4
Immunology: A Short Course
Clinically, allograft rejections fall into three major categories: (1) hyperacute
rejection, (2) acute rejection, and (3) chronic rejection. The following are
descriptions of the rejection reactions that might be observed after transplantation
of a kidney; ...
Richard Coico, Geoffrey Sunshine, 2009
5
Cancer Immunotherapy: Immune Suppression and Tumor Growth
HyperAcute Vaccines: A Novel Cancer Immunotherapy to suggest that
immunological parameters as well as delayed and complex clinical tumor
responses might be a more accurate way to determine efficacy in immunotherapy
trials.
George C. Prendergast, Elizabeth M. Jaffee, 2013
Hyperacute rejection of porcine organs by primates is initiated by complement-
fixing xenoreactive antibodies that bind to the endothelium of the newly
transplanted organ and activate the complement system (Platt et al. 1991). In
humans ...
Daniel R. Salomon, Carolyn Wilson, Carolyn Anne Wilson, 2003
7
Immunobiology of Organ Transplantation
The coordinated and extensive exposure of immobilized von Willebrand factor, P-
selectin and GP Ib-IX-V on both activated and injured endothelium and sub-
endothelium triggers platelet aggregation and coagulation. leading to hyperacute
...
David S. Wilkes, William J. Burlingham, 2004
8
Primer on Kidney Diseases
Hyperacute rejection leads to loss of the allograft, but it rarely occurs in modern
transplantation because of strict ABO matching and careful HLA cross-matching
before transplantation to exclude presensitized patients. Hyperacute rejection is ...
Arthur Greenberg, Alfred K. Cheung, 2005
9
Handbook of Laboratory Animal Science, Second Edition: ...
Animal models are used to study hyperacute rejection, acute vascular rejection,
acute cellular rejection, and chronic rejection. Small animal models have the
benefits of low cost, easy breeding, and the ready availability of transgenic
animals, ...
Jann Hau, Steven J. Schapiro, Gerald L. Van Hoosier, Jr., 2002
10
Magnetic Resonance Imaging in Stroke
In late subacute and chronic ICH, a hypoin- tense rim caused by the
paramagnetic effect of hemosiderin demarcates the border zone of the
hematoma, which is better seen on T2-WI than on T,-WI. Hyperacute ICH
presents as a non-specific ...
Stephen Davis, Marc Fisher, Steven Warach, 2003
包含词语«HYPERACUTE»的新条目
找出国内和国际出版社所讨论的内容，以及词语
hyperacute在以下新条目的上下文中是如何使用的。
NewLink Genetics Corp Director Sells $252,100.00 in Stock (NLNK …
Its biologic product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune ... «sleekmoney, 七月 15»
NewLink Genetics Corp Given Consensus Rating of "Buy" by …
Its biologic product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune ... «WKRB News, 七月 15»
NewLink Genetics Corp Receives $48.79 Average Target Price from …
Its biologic product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune ... «sleekmoney, 七月 15»
Charles J. Jr. Link Sells 20000 Shares of NewLink Genetics Corp …
Its biologic product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune ... «The Legacy, 七月 15»
NewLink Genetics Corp Receives Average Recommendation of …
Its biologic product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune system. «Dakota Financial News, 七月 15»
Company Shares of NewLink Genetics Corporation Drops by -0.34%
Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast ... «News Watch International, 六月 15»
NewLink Genetics Corporation Short Interest Update
Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast ... «OTC Outlook, 六月 15»
Company Shares of NewLink Genetics Corporation Rally 0.07%
Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast ... «American Trade Journal, 六月 15»
Patients full of praise for new stroke unit 30 miles away
A decision was taken by the Trust in November 2013 to temporarily consolidate hyperacute stroke services on its Scunthorpe site and in doing ... «Grimsby Telegraph, 六月 15»
Analyst Rating Update on NewLink Genetics Corporation
Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast ... «The Daily Rover, 六月 15»
